As filed with the Securities and Exchange Commission on March 12, 2025
Registration No. 333-       

    
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549



FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933



INNOVIZ TECHNOLOGIES LTD.
(Exact name of Registrant as specified in its charter)



State of Israel
Not applicable
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification Number)
 
 
5 Uri Ariav Street
Bldg. C.
Nitzba 300
Rosh HaAin, Israel
4809202
(Address of Principal Executive Offices)
(Zip Code)

Innoviz Technologies Ltd. 2021 Share Incentive Plan
(Full Title of the Plan)
 
Cogency Global Inc.
122 East 42nd Street, 18th Floor
New York, NY 10168
(800) 221-0102
(Name, address, including zip code, and telephone number, including area code, of agent for service)
 
Copies to:
 
Ryan J. Maierson
Ryan J. Lynch
Latham & Watkins LLP
811 Main Street, Suite 3700
Houston, Texas 77002
Tel: (713) 546-5400
Joshua G. Kiernan
Latham & Watkins LLP
99 Bishopsgate
London EC2M 3XF
United Kingdom
Tel: (+44) (20) 7710-1000
Tuvia J. Geffen, Adv.
Naschitz, Brandes, Amir & Co.
5 Tuval Street
Tel-Aviv 6789717, Israel
Tel: +972 3-623-5000
 



Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer
Accelerated filer
Non-accelerated filer
Smaller reporting company
 
 
Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.  


 EXPLANATORY NOTE
 
This registration statement on Form S-8 (this “Registration Statement”) is being filed with the Securities and Exchange Commission (the “Commission”) to register the offer, issuance and sale of an additional 7,187,592 ordinary shares, no par value (“Ordinary Shares”), of Innoviz Technologies Ltd. (the “Company,” the “Registrant,” “we” or “us”) issuable by the Registrant to its and/or its subsidiaries’ officers, employees, directors and consultants under the Innoviz Technologies Ltd. 2021 Share Incentive Plan (the “2021 Plan”).

On April 26, 2021, we filed with the Commission a registration statement on Form S-8 (File No. 333-255511) registering 9,820,588 Ordinary Shares that may be issued under the Innoviz Technologies Ltd. 2016 Share Incentive Plan and 19,510,820 Ordinary Shares that may be issued under the 2021 Plan.

 On May 24, 2022, we filed with the Commission a registration statement on Form S-8 (File No. 333-265169) registering an additional 1,014,520 Ordinary Shares that may be issued under the Registrant’s 2021 Plan.

On March 9, 2023, we filed with the Commission a registration statement on Form S-8 (File No. 333-270416) registering an additional 4,909,261 Ordinary Shares that may be issued under the Registrant’s 2021 Plan.

On March 12, 2024, we filed with the Commission a registration statement on Form S-8 (File No. 333-277852) registering an additional 8,021,536 Ordinary Shares that may be issued under the Registrant’s 2021 Plan.

The 2021 Plan provides that the number of Ordinary Shares available for issuance under the 2021 Plan will automatically increase on the first day of each calendar year of 2022 through 2031, to equal to the lesser of (A) 5% of the outstanding Ordinary Shares on the last day of the immediately preceding calendar year and (B) such amount as determined by our board of directors if so determined prior to January 1 of a calendar year; provided, however, that no more than 14,000,000 shares in total may be issued upon the exercise of incentive stock options, or ISOs, under the 2021 Plan.
 
The purpose of this Registration Statement is for the Registrant to register an additional 7,187,592 Ordinary Shares issuable under the 2021 Plan effective as of January 1, 2025, representing an increase to the number of Ordinary Shares available for issuance under the 2021 Plan in an amount equal to 5% of the outstanding Ordinary Shares as of December 31, 2024.

Pursuant to Instruction E of Form S-8, the contents of our prior registration statements on Form S-8 (File Nos. 333- 255511,333-265169, 333-270416 and 333-277852) are incorporated herein by reference, and the information required by Part II is omitted, except as supplemented by the information set forth below.

PART I
 
INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
 
The information called for in Part I of Form S-8 is not being filed with or included in this Form S-8 (by incorporation by reference or otherwise) in accordance with the rules and regulations of the Commission.
 
PART II
 
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
 
Item 3. Incorporation of Documents by Reference.
 
The Commission allows us to incorporate by reference information we filed with them, which means that we can disclose important information to you by referring you to those documents. The information incorporated by reference is considered to be part of this Registration Statement, and later information filed with the Commission will update and supersede this information. We hereby incorporate by reference into this Registration Statement the following documents previously filed with the Commission:
 
 
(a)
The Registrant’s Annual Report on Form 20-F for the year ended December 31, 2024 filed with the SEC on March 12, 2025 pursuant to Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”); and

 
(b)
The description of the Registrant’s Ordinary Shares contained in the Registrant’s registration statement on Form 8-A (File No. 001-40310), filed by the Registrant with the Commission under Section 12(b) of the Exchange Act on April 5, 2021 including any amendments or reports filed for the purpose of updating such description.
 
All documents that the Registrant subsequently files pursuant to Sections 13 or 15(d) of the Exchange Act prior to the filing of a post-effective amendment to the Registration Statement that indicates that all of the Ordinary Shares offered have been sold or that deregisters all of such shares then remaining unsold, shall be deemed to be incorporated by reference in this registration statement and to be a part hereof from the date of the filing of such documents.
 
Any statement contained herein or in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such earlier statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.
 

Item 8. Exhibits.
 
Exhibit
Number
 
Incorporated by Reference
Filed
Herewith
Exhibit Description
Form
Date
Number
F-3
5/24/22
3.1
 
F-4/A
2/12/21
4.5
 
 
 
 
*
 
 
 
*
 
 
 
*
 
 
 
*
 
 
 
*
20-F
3/30/22
4.4
 
 
 
 
 *
 

 
SIGNATURES
 
Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Rosh HaAin, Israel, on this 12 day of March, 2025.
 
 
INNOVIZ TECHNOLOGIES LTD.
 
 
 
By:
/s/ Eldar Cegla
 
 
 
Name: Eldar Cegla
 
 
 
Title: Chief Financial Officer
 
 
POWER OF ATTORNEY
 
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below does hereby constitute and appoint each of Omer David Keilaf and Eldar Cegla, with full power of substitution and full power to act without the other, as his or her true and lawful attorney-in-fact and agent to act for him or her in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement, and to file this Registration Statement, with all exhibits thereto, and other documents in connection therewith, with the Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in order to effectuate the same as fully, to all intents and purposes, as they or he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, may lawfully do or cause to be done by virtue hereof.
 
Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the date indicated.
 
NAME
 
POSITION
 
DATE
 
 
 
 
 
/s/ Omer David Keilaf
 
Chief Executive Officer and Director
 
March 12, 2025
Omer David Keilaf
 
(Principal Executive Officer)
 
 
 
 
 
 
 
/s/ Eldar Cegla
 
Chief Financial Officer
 
March 12, 2025
Eldar Cegla
 
(Principal Financial Officer and Principal Accounting Officer)
 
 
 
 
 
 
 
/s/ Amichai Steimberg
 
Director
 
March 12, 2025
Amichai Steimberg
 
 
 
 
 
 
 
 
 
/s/ Aharon Aharon
 
Director
 
March 12, 2025
Aharon Aharon
 
 
 
 
 
 
 
 
 
/s/ Dan Falk
 
Director
 
March 12, 2025
Dan Falk
 
 
 
 
 
 
 
 
 
/s/ Ronit Maor
 
Director
 
March 12, 2025
Ronit Maor
 
 
 
 
 
 
 
 
 
/s/ Orit Stav
 
Director
 
March 12, 2025
Orit Stav
 
 
 
 
 
 
 
 
 
/s/ James Sheridan
 
Director
 
March 12, 2025
James Sheridan
 
 
 
 
 
 
 
 
 
/s/ Stefan Jacoby
 
Director
 
March 12, 2025
Stefan Jacoby
 
 
 
 
 
 
 
 
 
/s/ Alexander von Witzleben
 
Director
 
March 12, 2025
Alexander von Witzleben
 
 
 
 


 
AUTHORIZED REPRESENTATIVE
 
Pursuant to the requirements of the Securities Act of 1933, as amended, the undersigned, the duly authorized representative in the United States of Innoviz Technologies Ltd. has signed this Registration Statement on March 12, 2025.
 
 
By:
/s/ Colleen De Vries
 
 
Name:
Colleen De Vries
 
 
Title:
SVP on behalf of Cogency Global Inc.
 
 


Exhibit 5.1


Tel-Aviv, March 12, 2025

Innoviz Technologies Ltd.
Innoviz Technologies Campus
5 Uri Ariav St., Bldg. C, Nitzba 300
Rosh HaAin 4809202
Israel

Ladies and Gentlemen:

Innoviz Technologies Ltd., a company organized under the laws of the State of Israel (the “Company”), has filed with the Securities and Exchange Commission a Registration Statement on Form S-8 (the “Registration Statement”), for the purpose of registering under the Securities Act of 1933, as amended (the “Securities Act”), 7,187,592 of its Ordinary Shares, no par value per share (the “Shares”), issuable under the Innoviz Technologies Ltd. 2021 Share Incentive Plan (the “Plan”).
 
As special Israeli counsel to the Company, we have examined such corporate records, certificates and other documents, and such questions of law, as we have considered necessary or appropriate for the purpose of our opinion.  Upon the basis of such examination, we are of the opinion that, when the Shares are issued and sold pursuant to the terms of the Plan and in accordance with the Registration Statement, the Shares will be legally and validly issued, fully paid and non-assessable.
 
The opinion expressed herein is limited to Israeli law, and we do not express any opinion as to the laws of any other jurisdiction.
 
We consent to the filing of this opinion as an exhibit to the Registration Statement. In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act.
 

Very truly yours,

/S/ Naschitz, Brandes, Amir & Co., Advocates
Naschitz, Brandes, Amir & Co., Advocates



Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of Innoviz Technologies Ltd. of our report dated March 12, 2025 relating to the financial statements, which appears in Innoviz Technologies Ltd.'s Annual Report on Form 20-F for the year ended December 31, 2024.
 
/s/ Kesselman & Kesselman
Certified Public Accountants (Isr.)
A member firm of PricewaterhouseCoopers International Limited

Tel Aviv, Israel
March 12, 2025

Kesselman & Kesselman, 146 Derech Menachem Begin St. Tel-Aviv 6492103, Israel,
P.O Box 7187 Tel-Aviv 6107120, Telephone: +972 -3- 7954555, Fax:+972 -3- 7954556, www.pwc.com/il



Exhibit 23.2

Consent of Independent Registered Public Accounting Firm
 
We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the 2021 Share Incentive Plan of Innoviz Technologies Ltd. of our report dated March 9, 2023, with respect to the consolidated financial statements of Innoviz Technologies Ltd. included in its Annual Report (Form 20-F) for the year ended December 31, 2024, filed with the Securities and Exchange Commission.
 
Tel-Aviv, Israel
/s/ KOST FORER GABBAY & KASIERER
March 12, 2025
A Member of EY Global  
 


Exhibit 107.1
Calculation of Filing Fee Tables
 
Form S-8
(Form Type)
 
 Innoviz Technologies Ltd.
(Exact Name of Registrant as Specified in its Charter)
 
Table 1: Newly Registered Securities
 
Security Type
Security Class Title
Fee Calculation Rule
Amount to be Registered(1)
Proposed Maximum Offering Price
Per Unit
Maximum Aggregate Offering Price
Fee Rate
Amount of
Registration Fee
Equity
Ordinary shares, no par value per share, reserved for issuance pursuant to the 2021 Plan
Rule 457(c) and Rule 457(h)
7,187,592 (2)
$0.686(3)
$4,930,688.11
$153.10 per $1,000,000
$754.89
Total Offering Amounts
$4,930,688.11
 
$754.89
Total Fee Offsets
 
 
$—
Net Fee Due
 
 
$754.89
__________________
(1)
Pursuant to Rule 416(a) under the Securities Act of 1933, as amended, this Registration Statement shall also cover any additional ordinary shares of the Registrant that become issuable under the Innoviz Technologies Ltd. 2021 Share Incentive Plan (the “2021 Plan”) by reason of any share dividend, share split, recapitalization or similar transaction effected without the Registrant’s receipt of consideration that would increase the number of outstanding ordinary shares.
(2)
Represents the additional 7,187,592 ordinary shares issuable under the Innoviz Technologies Ltd. 2021 Share Incentive Plan (the “2021 Plan”), representing an increase to the number of ordinary shares available for issuance under the 2021 Plan in an amount equal to 5% of the outstanding ordinary shares as of December 31, 2024.
(3)
Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(h) and Rule 457(c) promulgated under the Securities Act. The offering price per share and the aggregate offering price for shares reserved for future issuance under the 2021 Plan are based on the average of the high ($0.72) and low ($0.652) prices of ordinary shares on The Nasdaq Stock Market LLC on March 10, 2025.


Innoviz Technologies (NASDAQ:INVZW)
Historical Stock Chart
From Jun 2025 to Jul 2025 Click Here for more Innoviz Technologies Charts.
Innoviz Technologies (NASDAQ:INVZW)
Historical Stock Chart
From Jul 2024 to Jul 2025 Click Here for more Innoviz Technologies Charts.